1. Molecular Bases for the Regulation of NKG2D Ligands in Cancer
    Leticia Huergo-Zapico et al, 2014, Front. Immunol. CrossRef
  2. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
    Meriem Hasmim et al, 2015, Front. Immunol. CrossRef
  3. Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines
    Elena Ciaglia et al, 2018, Int. J. Cancer CrossRef
  4. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells
    Victor G. Martinez et al, 2017, Stem Cell Res Ther CrossRef
  5. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities
    Shanmugasundaram Ganapathy-Kanniappan, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  6. The Paradoxical Role of NKG2D in Cancer Immunity
    Sam Sheppard et al, 2018, Front. Immunol. CrossRef
  7. Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
    Jose M. Ayuso et al, 2018, OncoImmunology CrossRef
  8. The Hypoxia-adenosinergic Immunosuppression and Redirection of Immune Response in Tumor Microenvironment
    Akio Ohta et al, 2014 CrossRef
  9. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    S Chouaib et al, 2017, Oncogene CrossRef
  10. Natural Killer Cells for Osteosarcoma
    Nidale Tarek et al, 2014 CrossRef
  11. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    G Chitadze et al, 2013, Scand J Immunol CrossRef
  12. Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
    Andrea M. Chambers et al, 2019, Front. Mol. Biosci. CrossRef
  13. L’hypoxie tumorale
    Meriem Hasmim et al, 2014, Med Sci (Paris) CrossRef
  14. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells
    Daniela Schilling et al, 2015, Cell Stress and Chaperones CrossRef
  15. Blocking HIF-1α Following Radiotherapy to Prolong and Enhance the Immune Effects of Radiotherapy: A Hypothesis
    Ming Pingpo, 2014, Med Sci Monit CrossRef
  16. Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling
    Changfu Zhao et al, 2016, Journal of Bone Oncology CrossRef
  17. Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
    Muhammad Zaeem Noman et al, 2019, Cells CrossRef
  18. Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.
    Carla Riera-Domingo et al, 2020, Physiol Rev CrossRef
  19. Matrix Metalloproteinases’ Role in Tumor Microenvironment
    Georgina Gonzalez-Avila et al, 2020 CrossRef
  20. MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
    Paula Codo et al, 2014, Oncotarget CrossRef
  21. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
    Alireza Labani-Motlagh et al, 2020, Front. Immunol. CrossRef
  22. Natural Killer Cell Immunotherapy for Osteosarcoma
    Brian P. Tullius et al, 2020 CrossRef
  23. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia
    Li‑Jun Xu et al, 2018, Mol Med Report CrossRef
  24. The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
    Joanna Domagala et al, 2020, Cancers CrossRef
  25. Prospects for NK Cell Therapy of Sarcoma
    Mieszko Lachota et al, 2020, Cancers CrossRef
  26. Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?
    Xiaojie Zhang et al, 2019, Cancer Res CrossRef
  27. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand?
    Cong-Shan Yuan et al, 2021, Acta Biomaterialia CrossRef
  28. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration
    Yucheng Fu et al, 2021, Front. Cell Dev. Biol. CrossRef
  29. Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
    Hansol Lee et al, 2021, Cancers CrossRef
  30. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
    Kari A. Shaver et al, 2021, Front. Immunol. CrossRef
  31. Hot or Cold: Bioengineering Immune Contextures into In Vitro Patient-Derived Tumor Models
    Nathaniel Sheng Hua Too et al, 2021, Advanced Drug Delivery Reviews CrossRef
  32. Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?
    Goutham Hassan Venkatesh et al, 2021, OncoImmunology CrossRef
  33. Role of NK Cells in Tumor Progression
    Iñigo Terrén et al, 2022 CrossRef
  34. Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
    Rosa A. Castillo-Rodríguez et al, 2022, Cancers CrossRef
  35. Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
    Amber B. Jones et al, 2022, Cancers CrossRef
  36. The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
    Bassam Janji et al, 2022, Front. Immunol. CrossRef
  37. Stress-induced MICA and MICB molecules in oncology
    S. A. Yurevna et al, 2022, Med. immunol. CrossRef
  38. Overcoming tumor resistance mechanisms in CAR-NK cell therapy
    Antonio Valeri et al, 2022, Front. Immunol. CrossRef
  39. Natural killer cells and type 1 innate lymphoid cells in cancer
    Noella Lopes et al, 2023, Seminars in Immunology CrossRef
  40. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics
    Kassandra M. Coyle et al, 2023, Cancers CrossRef
  41. Precision medicine for diagnosis and treatment of osteosarcoma
    Rui Wang et al, 2016 CrossRef
  42. The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy
    Fatemeh Hajibabaie et al, 2023, Environmental Research CrossRef
  43. Alleviating hypoxia to improve cancer immunotherapy
    Peng Fan et al, 2023, Oncogene CrossRef
  44. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
    Raefa Abou Khouzam et al, 2023, Seminars in Cancer Biology CrossRef
  45. Blocking HIF to Enhance NK Cells: Hints for New Anti-Tumor Therapeutic Strategies?
    Massimo Vitale et al, 2021, Vaccines CrossRef
  46. Abnormal methylation of Mill1 gene regulates osteogenic differentiation involved in various phenotypes of skeletal fluorosis in rats and methionine intervention
    Niannian Chen et al, 2025, Ecotoxicology and Environmental Safety CrossRef